2-(Azetidin-3-yl)acetonitrile hydrochloride

Catalog No. :
ACGQCD184
CAS No. :
1423057-36-6
Molecular Formula :
C5H9ClN2
Molecular Weight :
132.59

IUPAC Name:2-(azetidin-3-yl)acetonitrile hydrochloride

2-(Azetidin-3-yl)acetonitrile hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$83.00Login to see priceIn stockInquiry
250mg95%$111.00Login to see priceIn stockInquiry
1g95%$236.00Login to see priceIn stockIn stock
5g95%$827.00Login to see priceIn stockIn stock
10g95%$1157.00Login to see priceIn stockIn stock
25g95%$2806.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Azetidin-3-yl)acetonitrile hydrochloride
IUPAC Name2-(azetidin-3-yl)acetonitrile hydrochloride
MDL No.MFCD28501222
Molecular FormulaC5H9ClN2
Molecular Weight132.59
SMILESN#CCC1CNC1.[H]Cl
InChI KeySJSKCHPFJJQTBK-UHFFFAOYSA-N
Synonym2-(azetidin-3-yl)acetonitrile hydrochloride | 1423057-36-6 | 2-(Azetidin-3-yl)acetonitrile HCl | 2-(azetidin-3-yl)acetonitrile;hydrochloride | SCHEMBL14697286 | AMY34671 | YGC05736 | MFCD28501222 | AKOS025289616 | SB11121 | AS-52277 | SY032761 | 2-(3-Azetidinyl)acetonitrile Hydr
CAS No.1423057-36-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACGQCD184 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBDPU190 route compound structure diagram
    ACBDPU190142253-58-5 In Stock
  2. Then
  3. ACGQCD184 route product structure diagram
    ACGQCD1841423057-36-6 In Stock
Inquiry

2. ACGQCD184 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGQCD184 route product structure diagram
    ACGQCD1841423057-36-6 In Stock
Inquiry

Comments (0)